Related Experiment Video
Updated: Jul 7, 2026

Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice
Published on: May 27, 2015
Mast cell activation disorders: mechanisms, comorbidities and look-alike
Theoharis C Theoharides1,2, Duraisamy Kempuraj1, Anne Maitland3
1Institute for Neuro-Immune Medicine, Dr. Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University, Ft. Lauderdale, FL, USA.
Introduction:
Mast Cells (MCs) are unique tissue perivascular immune cells found close to nerves at interfaces with the external environment. Upon detection of danger signals, MCs act as master responders aiming to restore homeostasis. If MCs are not optimally regulated, they can contribute to the pathogenesis of MC activation disorders (MCADs) and other neuroinflammatory conditions.
Areas Covered:
MCs respond to chemical, infectious, physical and stress stimuli leading to release of hundreds of proinflammatory, neurotoxic, tissue-disrupting and vasoactive mediators, known as MCA. The release of MC mediators can occur via different mechanisms without always release of tryptase. Among MCADs, the criteria for diagnosing mast cell activation syndrome (MCAS) require elevated serum tryptase or elevated urine MC mediator metabolites and/or multi-organ involvement. Patients with MCADs often present with comorbidities with suspected MCA or are mistaken for other conditions with similar symptomatology that worsen with stress, implicating neurohormonal processes. This review aims to clarify inconsistencies and misconceptions while providing practical suggestions for the clinician.
Expert Opinion:
MCA is present in many conditions that do not qualify as MCADs. Research is needed to better define and regulate MCA, leading to more accurate diagnosis and effective inhibitors for the treatment of MCADs and related disorders.
Related Concept Videos
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma I: Introduction
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Allergic Drug Reactions
Asthma III: Clinical Manifestations
